Skip to content

Immunowell Ebv Vca IGG Test

by Genbio

510(k) K973940

Immunowell Ebv Vca IGG Test is a medical device (FDA Class I; FDA product code LSE, Epstein-Barr Virus, Other) made by Genbio, cleared under FDA 510(k) K973940 on 10 Aug 1998, active as of 9 Oct 2026.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 9 Oct 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 9 Oct 2026.

Regulatory status

as of registry sync 9 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK973940 Date10 Aug 1998ClearedStatusActive

Official records

From the FDA record

Received by the FDA
15 Oct 1997
FDA decision
10 Aug 1998 (Substantially Equivalent)
FDA review time
299 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K973940 (openFDA), as read on 9 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
LSE
Device class
Class I
Regulation
21 CFR Part 866.3235
Advisory committee
Microbiology
FDA decision
SESE Substantially Equivalent

Similar devices

Other devices filed under FDA product code LSE (Epstein-Barr Virus, Other).

Other devices from Genbio

See all devices from Genbio →